| 1 | [SID85147291] | Active | Potency | 0.4449 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation using MMS Stimulated ELG1 [AID624249, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 0.4449 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation using MMS Stimulated ELG1 | | AID | 624249 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 2 | [SID85147291] | Active | Potency | 0.631 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 0.631 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID85147291] | Active | Potency | 0.6513 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 4 | [SID85147291] | Active | Potency | 0.7051 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability [AID624251, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 0.7051 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability | | AID | 624251 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 5 | [SID85147291] | Active | Potency | 0.8913 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 6 | [SID85147291] | Active | IC50 | 1.22 | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay [AID588524, Type: confirmatory] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 1.22 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay | | AID | 588524 | | BioAssay type | confirmatory | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 7 | [SID85147291] | Active | AC50 | 1.517 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | AC50 | 1.517 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID85147291] | Active | IC50 | 2.22 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 2.22 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 9 | [SID85147291] | Active | IC50 | 2.22 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 2.22 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 10 | [SID85147291] | Active | IC50 | 2.22 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 2.22 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 11 | [SID85147291] | Active | IC50 | 2.22 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 2.22 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 12 | [SID85147291] | Active | Potency | 2.3109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 2.3109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID85147291] | Active | Potency | 4.1078 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 4.1078 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 14 | [SID85147291] | Active | Potency | 4.6109 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID85147291] | Active | AC50 | 6.673 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | AC50 | 6.673 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID85147291] | Active | AC50 | 7.362 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | AC50 | 7.362 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID85147291] | Active | Potency | 7.9112 | HTS assay for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation [AID624248, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 7.9112 [uM] | | BioAssay | HTS assay for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1: Hit Confirmation | | AID | 624248 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 18 | [SID85147291] | Active | Potency | 8.8766 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with Unstimulated Viability Assay [AID624252, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 8.8766 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with Unstimulated Viability Assay | | AID | 624252 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 19 | [SID85147291] | Active | Potency | 12.5168 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks [AID651814, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 12.5168 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks | | AID | 651814 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 20 | [SID85147291] | Active | AC50 | 13.69 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | AC50 | 13.69 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID85147291] | Active | Potency | 14.0441 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen [AID651815, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 14.0441 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen | | AID | 651815 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 22 | [SID85147291] | Active | Potency | 15.7578 | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen [AID651813, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 15.7578 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen | | AID | 651813 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 23 | [SID85147291] | Active | Potency | 15.785 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with 5FU Viability [AID624250, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 15.785 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with 5FU Viability | | AID | 624250 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 24 | [SID85147291] | Active | Potency | 23.1093 | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID85147291] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID85147291] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 27 | [SID85147291] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 28 | [SID85147291] | Active | IC50 | 61.948 | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | IC50 | 61.948 [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 29 | [SID85147291] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 30 | [SID85147291] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 31 | [SID85147291] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 32 | [SID85147291] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 33 | [SID85147291] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID85147291] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID85147291] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID85147291] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 37 | [SID85147291] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 38 | [SID85147291] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 39 | [SID85147291] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 40 | [SID85147291] | Active | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 41 | [SID85147291] | Active | | | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID504614, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 504614 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 42 | [SID85147291] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 43 | [SID85147291] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) [AID602396, Type: screening] | NR5A2 gene product [Homo sapiens] [gi:4504343] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2) | | AID | 602396 | | BioAssay type | screening | | Target | NR5A2 gene product [Homo sapiens] [gi:4504343] | | PubMed | | | Data Table |  |
|
| 44 | [SID85147291] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 45 | [SID85147291] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 46 | [SID85147291] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 47 | [SID85147291] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 48 | [SID85147291] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 49 | [SID85147291] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID489028, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 489028 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 50 | [SID85147291] | Active | | | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2 [AID504601, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85147291 | | CID | 44143082 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2 | | AID | 504601 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|